The European Medicines Agency has held a preliminary meeting with the developers of the Russian Sputnik V COVID-19 vaccine to discuss the product’s development program with a view to evaluating it for possible EU approval. The agency clarified that the vaccine is not under review.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?